nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—Prazosin—CYP1A1—head and neck cancer	0.036	1	CrCbGaD
Alfuzosin—Neuralgia—Docetaxel—head and neck cancer	0.0176	0.0182	CcSEcCtD
Alfuzosin—Angina pectoris—Vinblastine—head and neck cancer	0.0157	0.0163	CcSEcCtD
Alfuzosin—Breast disorder—Hydroxyurea—head and neck cancer	0.0154	0.016	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Vinblastine—head and neck cancer	0.0141	0.0147	CcSEcCtD
Alfuzosin—Drowsiness—Hydroxyurea—head and neck cancer	0.0131	0.0136	CcSEcCtD
Alfuzosin—Infestation NOS—Hydroxyurea—head and neck cancer	0.0131	0.0136	CcSEcCtD
Alfuzosin—Infestation—Hydroxyurea—head and neck cancer	0.0131	0.0136	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.0129	0.0134	CcSEcCtD
Alfuzosin—Pharyngitis—Vinblastine—head and neck cancer	0.0128	0.0133	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.0124	0.0129	CcSEcCtD
Alfuzosin—Osteoarthritis—Fluorouracil—head and neck cancer	0.0123	0.0127	CcSEcCtD
Alfuzosin—Hepatocellular injury—Docetaxel—head and neck cancer	0.0122	0.0127	CcSEcCtD
Alfuzosin—Influenza like illness—Docetaxel—head and neck cancer	0.0119	0.0123	CcSEcCtD
Alfuzosin—Neuropathy—Docetaxel—head and neck cancer	0.0115	0.0119	CcSEcCtD
Alfuzosin—Angiopathy—Hydroxyurea—head and neck cancer	0.0107	0.0111	CcSEcCtD
Alfuzosin—Ill-defined disorder—Vinblastine—head and neck cancer	0.0105	0.0108	CcSEcCtD
Alfuzosin—Angina pectoris—Fluorouracil—head and neck cancer	0.0103	0.0107	CcSEcCtD
Alfuzosin—Malaise—Vinblastine—head and neck cancer	0.0102	0.0105	CcSEcCtD
Alfuzosin—Vertigo—Vinblastine—head and neck cancer	0.0101	0.0105	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00986	0.0102	CcSEcCtD
Alfuzosin—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00953	0.00989	CcSEcCtD
Alfuzosin—Discomfort—Vinblastine—head and neck cancer	0.00948	0.00983	CcSEcCtD
Alfuzosin—Infestation—Fluorouracil—head and neck cancer	0.00946	0.00982	CcSEcCtD
Alfuzosin—Infestation NOS—Fluorouracil—head and neck cancer	0.00946	0.00982	CcSEcCtD
Alfuzosin—Atrial fibrillation—Docetaxel—head and neck cancer	0.00935	0.0097	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00928	0.00962	CcSEcCtD
Alfuzosin—Malaise—Hydroxyurea—head and neck cancer	0.00926	0.00961	CcSEcCtD
Alfuzosin—Thrombocytopenia—Vinblastine—head and neck cancer	0.009	0.00934	CcSEcCtD
Alfuzosin—Sinusitis—Fluorouracil—head and neck cancer	0.00888	0.00921	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00869	0.00901	CcSEcCtD
Alfuzosin—Discomfort—Hydroxyurea—head and neck cancer	0.00864	0.00896	CcSEcCtD
Alfuzosin—Rhinitis—Fluorouracil—head and neck cancer	0.00852	0.00883	CcSEcCtD
Alfuzosin—Pharyngitis—Fluorouracil—head and neck cancer	0.00843	0.00875	CcSEcCtD
Alfuzosin—Oedema—Hydroxyurea—head and neck cancer	0.00838	0.0087	CcSEcCtD
Alfuzosin—Infection—Hydroxyurea—head and neck cancer	0.00833	0.00864	CcSEcCtD
Alfuzosin—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00822	0.00853	CcSEcCtD
Alfuzosin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00821	0.00852	CcSEcCtD
Alfuzosin—Skin disorder—Hydroxyurea—head and neck cancer	0.00814	0.00845	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00809	0.0084	CcSEcCtD
Alfuzosin—Abdominal pain upper—Docetaxel—head and neck cancer	0.00809	0.0084	CcSEcCtD
Alfuzosin—Breast disorder—Docetaxel—head and neck cancer	0.00801	0.00831	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00798	0.00828	CcSEcCtD
Alfuzosin—Constipation—Vinblastine—head and neck cancer	0.00786	0.00816	CcSEcCtD
Alfuzosin—Pain—Vinblastine—head and neck cancer	0.00786	0.00816	CcSEcCtD
Alfuzosin—Feeling abnormal—Vinblastine—head and neck cancer	0.00758	0.00786	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00752	0.0078	CcSEcCtD
Alfuzosin—Angina pectoris—Docetaxel—head and neck cancer	0.00746	0.00774	CcSEcCtD
Alfuzosin—Somnolence—Hydroxyurea—head and neck cancer	0.00745	0.00773	CcSEcCtD
Alfuzosin—Dyspepsia—Hydroxyurea—head and neck cancer	0.00738	0.00766	CcSEcCtD
Alfuzosin—Abdominal pain—Vinblastine—head and neck cancer	0.00727	0.00754	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00724	0.00751	CcSEcCtD
Alfuzosin—Fatigue—Hydroxyurea—head and neck cancer	0.00723	0.0075	CcSEcCtD
Alfuzosin—Constipation—Hydroxyurea—head and neck cancer	0.00717	0.00744	CcSEcCtD
Alfuzosin—Pain—Hydroxyurea—head and neck cancer	0.00717	0.00744	CcSEcCtD
Alfuzosin—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00691	0.00717	CcSEcCtD
Alfuzosin—Infestation NOS—Docetaxel—head and neck cancer	0.00683	0.00709	CcSEcCtD
Alfuzosin—Infestation—Docetaxel—head and neck cancer	0.00683	0.00709	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Docetaxel—head and neck cancer	0.0067	0.00694	CcSEcCtD
Alfuzosin—Jaundice—Docetaxel—head and neck cancer	0.00666	0.00691	CcSEcCtD
Alfuzosin—Asthenia—Vinblastine—head and neck cancer	0.0066	0.00684	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00646	0.0067	CcSEcCtD
Alfuzosin—Chest pain—Fluorouracil—head and neck cancer	0.0063	0.00653	CcSEcCtD
Alfuzosin—Diarrhoea—Vinblastine—head and neck cancer	0.00629	0.00653	CcSEcCtD
Alfuzosin—Discomfort—Fluorouracil—head and neck cancer	0.00622	0.00645	CcSEcCtD
Alfuzosin—Rhinitis—Docetaxel—head and neck cancer	0.00615	0.00638	CcSEcCtD
Alfuzosin—Pharyngitis—Docetaxel—head and neck cancer	0.00609	0.00631	CcSEcCtD
Alfuzosin—Dizziness—Vinblastine—head and neck cancer	0.00608	0.00631	CcSEcCtD
Alfuzosin—Urinary tract disorder—Docetaxel—head and neck cancer	0.00606	0.00628	CcSEcCtD
Alfuzosin—Oedema—Fluorouracil—head and neck cancer	0.00604	0.00626	CcSEcCtD
Alfuzosin—Connective tissue disorder—Docetaxel—head and neck cancer	0.00603	0.00625	CcSEcCtD
Alfuzosin—Asthenia—Hydroxyurea—head and neck cancer	0.00602	0.00624	CcSEcCtD
Alfuzosin—Urethral disorder—Docetaxel—head and neck cancer	0.00601	0.00623	CcSEcCtD
Alfuzosin—Infection—Fluorouracil—head and neck cancer	0.006	0.00622	CcSEcCtD
Alfuzosin—Nervous system disorder—Fluorouracil—head and neck cancer	0.00592	0.00614	CcSEcCtD
Alfuzosin—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00591	0.00613	CcSEcCtD
Alfuzosin—Tachycardia—Fluorouracil—head and neck cancer	0.00589	0.00611	CcSEcCtD
Alfuzosin—Vomiting—Vinblastine—head and neck cancer	0.00585	0.00606	CcSEcCtD
Alfuzosin—Headache—Vinblastine—head and neck cancer	0.00576	0.00597	CcSEcCtD
Alfuzosin—Diarrhoea—Hydroxyurea—head and neck cancer	0.00574	0.00595	CcSEcCtD
Alfuzosin—Eye disorder—Docetaxel—head and neck cancer	0.00573	0.00594	CcSEcCtD
Alfuzosin—Flushing—Docetaxel—head and neck cancer	0.00569	0.0059	CcSEcCtD
Alfuzosin—Cardiac disorder—Docetaxel—head and neck cancer	0.00569	0.0059	CcSEcCtD
Alfuzosin—Hypotension—Fluorouracil—head and neck cancer	0.00564	0.00585	CcSEcCtD
Alfuzosin—Angiopathy—Docetaxel—head and neck cancer	0.00556	0.00577	CcSEcCtD
Alfuzosin—Dizziness—Hydroxyurea—head and neck cancer	0.00554	0.00575	CcSEcCtD
Alfuzosin—Mediastinal disorder—Docetaxel—head and neck cancer	0.00553	0.00573	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.0055	0.0057	CcSEcCtD
Alfuzosin—Nausea—Vinblastine—head and neck cancer	0.00546	0.00567	CcSEcCtD
Alfuzosin—Mental disorder—Docetaxel—head and neck cancer	0.00537	0.00557	CcSEcCtD
Alfuzosin—Somnolence—Fluorouracil—head and neck cancer	0.00537	0.00557	CcSEcCtD
Alfuzosin—Vomiting—Hydroxyurea—head and neck cancer	0.00533	0.00553	CcSEcCtD
Alfuzosin—Dyspepsia—Fluorouracil—head and neck cancer	0.00531	0.00551	CcSEcCtD
Alfuzosin—Rash—Hydroxyurea—head and neck cancer	0.00529	0.00548	CcSEcCtD
Alfuzosin—Dermatitis—Hydroxyurea—head and neck cancer	0.00528	0.00548	CcSEcCtD
Alfuzosin—Headache—Hydroxyurea—head and neck cancer	0.00525	0.00545	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00521	0.00541	CcSEcCtD
Alfuzosin—Back pain—Docetaxel—head and neck cancer	0.00516	0.00536	CcSEcCtD
Alfuzosin—Pain—Fluorouracil—head and neck cancer	0.00516	0.00535	CcSEcCtD
Alfuzosin—Nausea—Hydroxyurea—head and neck cancer	0.00498	0.00517	CcSEcCtD
Alfuzosin—Feeling abnormal—Fluorouracil—head and neck cancer	0.00497	0.00516	CcSEcCtD
Alfuzosin—Urticaria—Fluorouracil—head and neck cancer	0.00479	0.00497	CcSEcCtD
Alfuzosin—Syncope—Docetaxel—head and neck cancer	0.00479	0.00497	CcSEcCtD
Alfuzosin—Palpitations—Docetaxel—head and neck cancer	0.00472	0.00489	CcSEcCtD
Alfuzosin—Loss of consciousness—Docetaxel—head and neck cancer	0.00469	0.00487	CcSEcCtD
Alfuzosin—Chest pain—Docetaxel—head and neck cancer	0.00454	0.00471	CcSEcCtD
Alfuzosin—Arthralgia—Docetaxel—head and neck cancer	0.00454	0.00471	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00451	0.00468	CcSEcCtD
Alfuzosin—Dry mouth—Docetaxel—head and neck cancer	0.00444	0.00461	CcSEcCtD
Alfuzosin—Oedema—Docetaxel—head and neck cancer	0.00436	0.00452	CcSEcCtD
Alfuzosin—Infection—Docetaxel—head and neck cancer	0.00433	0.00449	CcSEcCtD
Alfuzosin—Shock—Docetaxel—head and neck cancer	0.00429	0.00445	CcSEcCtD
Alfuzosin—Nervous system disorder—Docetaxel—head and neck cancer	0.00427	0.00443	CcSEcCtD
Alfuzosin—Pruritus—Fluorouracil—head and neck cancer	0.00427	0.00443	CcSEcCtD
Alfuzosin—Thrombocytopenia—Docetaxel—head and neck cancer	0.00427	0.00442	CcSEcCtD
Alfuzosin—Tachycardia—Docetaxel—head and neck cancer	0.00425	0.00441	CcSEcCtD
Alfuzosin—Skin disorder—Docetaxel—head and neck cancer	0.00423	0.00439	CcSEcCtD
Alfuzosin—Diarrhoea—Fluorouracil—head and neck cancer	0.00413	0.00428	CcSEcCtD
Alfuzosin—Hypotension—Docetaxel—head and neck cancer	0.00407	0.00422	CcSEcCtD
Alfuzosin—Dizziness—Fluorouracil—head and neck cancer	0.00399	0.00414	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00397	0.00412	CcSEcCtD
Alfuzosin—Somnolence—Docetaxel—head and neck cancer	0.00387	0.00402	CcSEcCtD
Alfuzosin—Vomiting—Fluorouracil—head and neck cancer	0.00384	0.00398	CcSEcCtD
Alfuzosin—Dyspepsia—Docetaxel—head and neck cancer	0.00383	0.00398	CcSEcCtD
Alfuzosin—Rash—Fluorouracil—head and neck cancer	0.00381	0.00395	CcSEcCtD
Alfuzosin—Dermatitis—Fluorouracil—head and neck cancer	0.0038	0.00394	CcSEcCtD
Alfuzosin—Headache—Fluorouracil—head and neck cancer	0.00378	0.00392	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00376	0.0039	CcSEcCtD
Alfuzosin—Fatigue—Docetaxel—head and neck cancer	0.00376	0.0039	CcSEcCtD
Alfuzosin—Pain—Docetaxel—head and neck cancer	0.00373	0.00386	CcSEcCtD
Alfuzosin—Constipation—Docetaxel—head and neck cancer	0.00373	0.00386	CcSEcCtD
Alfuzosin—Feeling abnormal—Docetaxel—head and neck cancer	0.00359	0.00372	CcSEcCtD
Alfuzosin—Nausea—Fluorouracil—head and neck cancer	0.00358	0.00372	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00356	0.0037	CcSEcCtD
Alfuzosin—Abdominal pain—Docetaxel—head and neck cancer	0.00344	0.00357	CcSEcCtD
Alfuzosin—Asthenia—Docetaxel—head and neck cancer	0.00313	0.00324	CcSEcCtD
Alfuzosin—Pruritus—Docetaxel—head and neck cancer	0.00308	0.0032	CcSEcCtD
Alfuzosin—Diarrhoea—Docetaxel—head and neck cancer	0.00298	0.00309	CcSEcCtD
Alfuzosin—Dizziness—Docetaxel—head and neck cancer	0.00288	0.00299	CcSEcCtD
Alfuzosin—Vomiting—Docetaxel—head and neck cancer	0.00277	0.00287	CcSEcCtD
Alfuzosin—Rash—Docetaxel—head and neck cancer	0.00275	0.00285	CcSEcCtD
Alfuzosin—Dermatitis—Docetaxel—head and neck cancer	0.00274	0.00285	CcSEcCtD
Alfuzosin—Headache—Docetaxel—head and neck cancer	0.00273	0.00283	CcSEcCtD
Alfuzosin—Nausea—Docetaxel—head and neck cancer	0.00259	0.00268	CcSEcCtD
